Focus On Equipment And Software For Validating Continuous Manufacturing Processes – FDA
Executive Summary
US FDA officials outline the agency’s expectations for validating processes for drugs manufactured on a continuous line and see growing interest among manufacturers in developing continuous manufacturing systems.
You may also be interested in...
FDA Ushers In Era of New Drug Manufacturing Technologies
FDA's Emerging Technology Team is guiding a diverse array of new manufacturing technologies through the agency's regulatory review process that could add market niches and possibly even fundamentally restructure the pharmaceutical industry.
FDA Tries to Clear Up Continuous Manufacturing Ambiguities
FDA seeks “creative” solutions to clear up the regulatory ambiguities associated with continuous manufacturing. Agency also notes “teething problems” with continuous manufacturing implementation.
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”